{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:36:06Z","timestamp":1766158566036,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10620-020-06586-8","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T15:02:36Z","timestamp":1599318156000},"page":"2805-2815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7891-5986","authenticated-orcid":false,"given":"Hiroaki","family":"Nozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenobu","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Murono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"6586_CR1","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484\u20133488.","journal-title":"Blood"},{"key":"6586_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715\u2013722.","journal-title":"JAMA"},{"key":"6586_CR3","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1253\/circj.CJ-19-0515","volume":"83","author":"J Sakamoto","year":"2019","unstructured":"Sakamoto J, Yamashita Y, Morimoto T, et al. Cancer-associated venous thromboembolism in the real world\u2014from the COMMAND VTE registry. Circ J. 2019;83:2271\u20132281.","journal-title":"Circ J"},{"key":"6586_CR4","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, B\u00fcller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved International Normalized Ratio: a retrospective analysis. J Clin Oncol. 2000;18:3078\u20133083.","journal-title":"J Clin Oncol"},{"key":"6586_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00000658-198808000-00016","volume":"208","author":"GP Clagett","year":"1998","unstructured":"Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1998;208:227\u2013240.","journal-title":"Ann Surg"},{"key":"6586_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/bjs.1800840817","volume":"84","author":"ENOXACAN Study Group","year":"1997","unstructured":"ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg. 1997;84:1099\u20131103.","journal-title":"Br J Surg"},{"key":"6586_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/bjs.5154","volume":"92","author":"G Agnelli","year":"2005","unstructured":"Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M, PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg. 2005;92:1212\u20131220.","journal-title":"Br J Surg"},{"key":"6586_CR8","first-page":"CD009447","volume":"7","author":"CF Matar","year":"2018","unstructured":"Matar CF, Kahale LA, Hakoum MB, et al. Anticoagulation for perioperative thromboprophylaxis in people with cancer. Cochrane Database Syst Rev. 2018;7:CD009447.","journal-title":"Cochrane Database Syst Rev"},{"key":"6586_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/clpt.2012.40","volume":"92","author":"AH Harrill","year":"2012","unstructured":"Harrill AH, Roach J, Fier I, et al. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin Pharmacol Ther. 2012;92:214\u2013220.","journal-title":"Clin Pharmacol Ther"},{"key":"6586_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bcp.12611","volume":"80","author":"E Raschi","year":"2015","unstructured":"Raschi E, Poluzzi E, Koci A, et al. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system. Br J Clin Pharmacol. 2015;80:285\u2013293.","journal-title":"Br J Clin Pharmacol"},{"key":"6586_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1055\/s-0038-1660139","volume":"54","author":"G Bratt","year":"1985","unstructured":"Bratt G, T\u00f6rnebohm E, Granqvist S, Aberg W, Lockner D. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thromb Haemost. 1985;54:813\u2013817.","journal-title":"Thromb Haemost"},{"key":"6586_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/s-2007-1002654","volume":"17","author":"HM Christiansen","year":"1991","unstructured":"Christiansen HM, Lassen MR, Borris LC, et al. Biologic tolerance of two different low molecular weight heparins. Semin Thromb Hemost. 1991;17:450\u2013454.","journal-title":"Semin Thromb Hemost"},{"key":"6586_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1592\/phco.21.1.108.34436","volume":"21","author":"MK Carlson","year":"2001","unstructured":"Carlson MK, Gleason PP, Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. Pharmacotherapy. 2001;21:108\u2013113.","journal-title":"Pharmacotherapy"},{"key":"6586_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/00912700122010465","volume":"41","author":"CK Hui","year":"2001","unstructured":"Hui CK, Yuen MF, Ng IO, Tsang KW, Fong GC, Lai CL. Low molecular weight heparin-induced liver toxicity. J Clin Pharmacol. 2001;41:691\u2013694.","journal-title":"J Clin Pharmacol"},{"key":"6586_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2146\/ajhp080311","volume":"66","author":"EL Baker","year":"2009","unstructured":"Baker EL, Loewenthal T, Salerno E, Baker WL. Probable enoxaparin-induced hepatotoxicity. Am J Health Syst Pharm. 2009;66:638\u2013641.","journal-title":"Am J Health Syst Pharm"},{"key":"6586_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40800-015-0018-0","volume":"2","author":"KJ Hahn","year":"2015","unstructured":"Hahn KJ, Morales SJ, Lewis JH. Enoxaparin-induced liver injury: case report and review of the literature and FDA adverse event reporting system (FAERS). Drug Saf Case Rep. 2015;2:17.","journal-title":"Drug Saf Case Rep"},{"key":"6586_CR17","doi-asserted-by":"publisher","first-page":"bcr2016216592","DOI":"10.1136\/bcr-2016-216592","volume":"2016","author":"KA Pivarnik","year":"2016","unstructured":"Pivarnik KA, Schiffman F, Sullivan J, Finn A. Enoxaparin-induced hepatotoxicity: an under-recognised complication of enoxaparin therapy. BMJ Case Rep. 2016;2016:bcr2016216592.","journal-title":"BMJ Case Rep"},{"key":"6586_CR18","first-page":"7649","volume":"23","author":"M Leo","year":"2019","unstructured":"Leo M, Ponziani FR, Nesci A, et al. Low molecular weight heparin as cause of liver injury: case report and literature review. Eur Rev Med Pharmacol Sci. 2019;23:7649\u20137654.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6586_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000508471","volume":"14","author":"S Mehershahi","year":"2020","unstructured":"Mehershahi S, Mantri N, Kumar A, Danial S, Harish P. Enoxaparin-induced liver injury. Case Rep Gastroenterol. 2020;14:315\u2013319.","journal-title":"Case Rep Gastroenterol"},{"key":"6586_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gut.2008.163675","volume":"58","author":"S Verma","year":"2009","unstructured":"Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut. 2009;58:1555\u20131564.","journal-title":"Gut"},{"key":"6586_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0034-1375952","volume":"34","author":"PH Hayashi","year":"2014","unstructured":"Hayashi PH, Fontana RJ. Clinical features, diagnosis, and natural history of drug-induced liver injury. Semin Liver Dis. 2014;34:134\u2013144.","journal-title":"Semin Liver Dis"},{"key":"6586_CR22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/liv.12540","volume":"35","author":"PH Hayashi","year":"2015","unstructured":"Hayashi PH, Barnhart HX, Fontana RJ, et al. Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN). Liver Int. 2015;35:1623\u20131632.","journal-title":"Liver Int"},{"key":"6586_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","volume":"11","author":"C B\u00e9nichou","year":"1990","unstructured":"B\u00e9nichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol. 1990;11:272\u2013276.","journal-title":"J Hepatol"},{"key":"6586_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323\u20131330.","journal-title":"J Clin Epidemiol"},{"key":"6586_CR25","volume-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","author":"HJ Zimmerman","year":"1999","unstructured":"Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.","edition":"2"},{"key":"6586_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1211","volume":"15","author":"R Temple","year":"2006","unstructured":"Temple R. Hy\u2019s law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf. 2006;15:241\u2013243.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6586_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u2013213.","journal-title":"Ann Surg"},{"key":"6586_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2106\/00004623-199401000-00002","volume":"76","author":"CW Colwell Jr","year":"1994","unstructured":"Colwell CW Jr, Spiro TE, Trowbridge AA, et al. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 1994;76:3\u201314.","journal-title":"J Bone Joint Surg Am"},{"key":"6586_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2106\/00004623-200103000-00004","volume":"83","author":"PC Comp","year":"2001","unstructured":"Comp PC, Spiro TE, Friedman RJ, et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg Am. 2001;83:336\u2013345.","journal-title":"J Bone Joint Surg Am"},{"key":"6586_CR30","unstructured":"Product Monograph PrLOVENOX\u00ae. Available at: http:\/\/products.sanofi.ca\/en\/lovenox.pdf#search=%27Lovenox+package+insert%27. Accessed May 17, 2020."},{"key":"6586_CR31","first-page":"73","volume":"6","author":"S David","year":"2010","unstructured":"David S, Hamilton JP. Drug-induced liver injury. US Gastroenterol Hepatol Rev. 2010;6:73\u201380.","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"6586_CR32","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","volume":"138","author":"N Chalasani","year":"2010","unstructured":"Chalasani N, Bj\u00f6rnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138:2246\u20132259.","journal-title":"Gastroenterology"},{"key":"6586_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jss.2018.03.022","volume":"229","author":"H Cheng","year":"2018","unstructured":"Cheng H, Clymer JW, Po-Han Chen B, et al. Prolonged operative duration is associated with complications: a systematic review and meta-analysis. J Surg Res. 2018;229:134\u2013144.","journal-title":"J Surg Res"},{"key":"6586_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00268-017-4170-9","volume":"42","author":"M Kaffarnik","year":"2018","unstructured":"Kaffarnik M, Stoeger G, Liebich J, Grieser C, Pratschke J, Stockmann M. Liver function, quantified by LiMAx test, after major abdominal surgery. Comparison between open and laparoscopic approach. World J Surg. 2018;42:557\u2013566.","journal-title":"World J Surg"},{"key":"6586_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/SLA.0000000000000340","volume":"259","author":"MC Vedovati","year":"2014","unstructured":"Vedovati MC, Becattini C, Rondelli F, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259:665\u2013669.","journal-title":"Ann Surg"},{"key":"6586_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/BF02237127","volume":"42","author":"YH Ho","year":"1999","unstructured":"Ho YH, Seow-Choen F, Leong A, Eu KW, Nyam D, Teoh MK. Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum. 1999;42:196\u2013203.","journal-title":"Dis Colon Rectum"},{"key":"6586_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ags3.12279","volume":"3","author":"T Hata","year":"2019","unstructured":"Hata T, Yasui M, Ikeda M, et al. Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Ann Gastroenterol Surg. 2019;3:568\u2013575.","journal-title":"Ann Gastroenterol Surg"},{"key":"6586_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00595-019-01859-w","volume":"50","author":"K Nakagawa","year":"2020","unstructured":"Nakagawa K, Watanabe J, Ota M, et al. Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surg Today. 2020;50:68\u201375.","journal-title":"Surg Today"},{"key":"6586_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/SLA.0b013e31815792d8","volume":"246","author":"NT Nguyen","year":"2007","unstructured":"Nguyen NT, Hinojosa MW, Fayad C, et al. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Ann Surg. 2007;246:1021\u20131027.","journal-title":"Ann Surg"},{"key":"6586_CR40","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/DCR.0b013e31823302a1","volume":"54","author":"R Shapiro","year":"2011","unstructured":"Shapiro R, Vogel JD, Kiran RP. Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum. 2011;54:1496\u20131502.","journal-title":"Dis Colon Rectum"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06586-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:22:05Z","timestamp":1630797725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06586-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6586"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06586-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"17 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with ethical standards of the Institutional Review Boards at the University of Tokyo (No. 3252-9) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethnical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}